Improving early breast cancer detection with advanced biopsy techniques
Rapid Histologic Assessment for Stereotactic Breast Biopsy: Enhancing Early Detection With Miniature Mass Spectrometry and AI
This study tests if using advanced technology during breast biopsies can help doctors find cancer earlier and give patients their results faster.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 20 Years to 99 Years |
| Sex | Female |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Trial ID | NCT06663228 on ClinicalTrials.gov |
What this trial studies
This study focuses on enhancing the early detection of breast cancer through rapid histologic assessment during stereotactic breast biopsies using miniature mass spectrometry and artificial intelligence. By providing quicker pathology results, the study aims to reduce the waiting time for patients, allowing for timely treatment decisions. The approach leverages advanced technology to improve diagnostic accuracy and efficiency in identifying malignant lesions. This observational study will involve patients undergoing vacuum-assisted stereotactic breast biopsy.
Who should consider this trial
Good fit: Ideal candidates for this study are women scheduled for vacuum-assisted stereotactic breast biopsy due to suspicious lesions.
Not a fit: Patients who are unable or unwilling to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the anxiety of patients awaiting biopsy results and improve early treatment outcomes for breast cancer.
How similar studies have performed: While the use of advanced technologies like miniature mass spectrometry and AI in breast cancer diagnostics is promising, this specific approach is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Those who come for receiving vacuum-assisted stereotactic breast biopsy Exclusion Criteria: * Those who cannot or are unwilling to sign the informed consent.
Where this trial is running
Taipei
- Jo-Yu Chen — Taipei, Taiwan (Recruiting)
Study contacts
- Study coordinator: Jo-Yu Chen, MD
- Email: joyuchen@ntuh.gov.tw
- Phone: +886223123456
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.